Verschuur Els M L, Kuipers Ernst J, Siersema Peter D
Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Gastrointest Endosc. 2007 Dec;66(6):1082-90. doi: 10.1016/j.gie.2007.03.1087. Epub 2007 Sep 12.
Self-expanding stents are a well-accepted palliative treatment modality for strictures resulting from esophageal carcinoma. However, the use of stents close to the upper esophageal sphincter (UES) is considered to be limited by patient intolerance caused by pain and globus sensation and an increased risk of complications, particularly tracheoesophageal fistula formation and aspiration pneumonia.
Our purpose was to determine the efficacy and safety of stent placement in patients with a malignant obstruction close to the UES.
Evaluation of 104 patients with dysphagia from a malignant stricture close to the UES treated in the period 1996-2006.
Single university center.
Patients with primary esophageal carcinoma (n = 66) or recurrent cancer after gastric tube interposition (n = 38) within 8 cm distance distal of the UES. Twenty-four (23%) patients also had a tracheoesophageal fistula.
Stent placement.
Functional and technical outcome, survival, complications, and recurrent dysphagia. Analyses were performed by chi(2) test, Kaplan-Meier curves, and log-rank testing.
Mean distance from the UES to the upper tumor margin was 4.9 +/- 2.6 cm and to the upper stent margin 3.1 +/- 2.3 cm. The procedure was technically successful in 100 of 104 (96%) patients. Fistula sealing was achieved in 19 of 24 (79%) patients. After 4 weeks, dysphagia had improved from a median score of 3 (liquids only) to 1 (some difficulties with solids). Total complications were seen in 34 of 104 (33%) patients. Of these, major complications (aspiration pneumonia [9], hemorrhage [8], fistula [7], and perforation [2]) occurred in 22 (21%) patients, whereas pain after stent placement was observed in 16 (15%) patients. Recurrent dysphagia occurred in 29 (28%) patients and was mainly caused by tissue ingrowth or overgrowth (n = 10), food bolus obstruction (n = 7), stent migration (n = 3), or other reasons (n = 11), such as persistent fistula (n = 5), difficulty with swallowing (n = 4), and dislocation of the stent (n = 2). Eight (8%) patients complained of globus sensation; however, in none of the patients was stent removal indicated.
Retrospective design.
Stent placement is safe and effective for the palliation of dysphagia and sealing of fistulas in patients with a malignant stricture close to the UES. On the basis of these results, stent placement may be considered for palliation in this group of patients with an otherwise dismal prognosis.
自膨式支架是食管癌所致狭窄一种广泛接受的姑息治疗方式。然而,靠近食管上括约肌(UES)处使用支架被认为受限于疼痛和咽喉异物感引起的患者不耐受以及并发症风险增加,尤其是气管食管瘘形成和吸入性肺炎。
我们的目的是确定在靠近UES处有恶性梗阻的患者中放置支架的疗效和安全性。
对1996 - 2006年期间治疗的104例因靠近UES的恶性狭窄导致吞咽困难的患者进行评估。
单一大学中心。
UES远端8 cm范围内患有原发性食管癌(n = 66)或胃管置入术后复发癌(n = 38)的患者。24例(23%)患者还患有气管食管瘘。
放置支架。
功能和技术结果、生存率、并发症及复发性吞咽困难。通过卡方检验、Kaplan - Meier曲线和对数秩检验进行分析。
从UES到肿瘤上缘的平均距离为4.9±2.6 cm,到支架上缘的平均距离为3.1±2.3 cm。该操作在104例患者中的100例(96%)技术成功。24例患者中的19例(79%)实现了瘘口封闭。4周后,吞咽困难从中位数评分3(仅能吞咽液体)改善至1(吞咽固体有一些困难)。104例患者中的34例(33%)出现了总并发症。其中,主要并发症(吸入性肺炎[9例]、出血[8例]、瘘[7例]和穿孔[2例])发生在22例(21%)患者中,而16例(15%)患者观察到放置支架后疼痛。29例(28%)患者出现复发性吞咽困难,主要由组织向内生长或过度生长(n = 10)、食物团块梗阻(n = 7)、支架移位(n = 3)或其他原因(n = 11)引起,如持续性瘘(n = 5)、吞咽困难(n = 4)和支架脱位(n = 2)。8例(8%)患者主诉有咽喉异物感;然而,没有患者需要取出支架。
回顾性设计。
对于靠近UES的恶性狭窄患者,放置支架缓解吞咽困难和封闭瘘口是安全有效的。基于这些结果,对于这组预后不佳的患者,可考虑放置支架进行姑息治疗。